CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Alfentanil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03359395
NCT03359395Phase 4Completed
CompareCT.gov

Effects of Pre-medication With Alfentanil on Hemodynamics During and Immediately Following Electroconvulsive Therapy (ECT)

Wake Forest University Health Sciences·interventional·Posted Dec 2, 2017·Updated Jul 8, 2021

In Brief

A Phase 4 clinical trial evaluating Alfentanil and Placebos for Blood Pressure and Electroconvulsive Therapy. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Hemodynamic changes associated with the conduct of electroconvulsive therapy may be minimized with the administration of alfentanil as part of their anesthetic regimen. This study proposes to compare the effects in a blinded fashion. Currently alfentanil is an FDA approved drug used on a daily basis by anesthesiologists on other surgeries so this is not a new indication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Pressure, Electroconvulsive Therapy
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedDec 2, 2017
Enrollment StartJun 4, 2018
Primary CompletionFeb 17, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.6 years ago

Interventions

Alfentanildrug

Administration of alfentanil during the induction and maintenance of anesthesia for electroconvulsive therapy to be performed

Placebosdrug

Administration of a equidose placebo during the induction and maintenance of anesthesia for electroconvulsive therapy to be performed